Sign up to save your podcasts
Or
Share Pt. 2 What Every Pharma Marketer Should Know About Naming a New Drug: A Conversation with Addison Whitney
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pt. 2 What Every Pharma Marketer Should Know About Naming a New Drug: A Conversation with Addison Whitney
Naming a new drug is a complex process. So much so that we needed to dedicate two episodes to the topic. Co-hosts John Hinkle and Will Brown discuss the ins and outs, and the do's and don'ts when it comes to naming drugs with two specialists: Nancy Globus and Jennifer Sirop with Addison Whitney. Nancy is VP of Regulatory and Medication Safety and Jennifer is VP of Trademarks. During this 2 episode special, we have an in-depth conversation about best practices and possible landmines to avoid when it comes to naming a new drug.
View all episodes
By PM 411 MediaNaming a new drug is a complex process. So much so that we needed to dedicate two episodes to the topic. Co-hosts John Hinkle and Will Brown discuss the ins and outs, and the do's and don'ts when it comes to naming drugs with two specialists: Nancy Globus and Jennifer Sirop with Addison Whitney. Nancy is VP of Regulatory and Medication Safety and Jennifer is VP of Trademarks. During this 2 episode special, we have an in-depth conversation about best practices and possible landmines to avoid when it comes to naming a new drug.